D-0041-2024 Class II Ongoing
FDA drug recall D-0041-2024 was initiated by Eugia US LLC on Sep 28, 2023 and is designated Class II. Reason for recall: Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial. The recall status is ongoing. Affected quantity: 1,626 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 11, 2023
- Initiation Date
- Sep 28, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,626 vials
Product description
Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intra-articular use only, Shake Well, Not for IV/ID, intraocular, epidural, or intrathecal use, Mfd. in India for Auromedics Pharma LLC., E Windsor, NJ, 08520, NDC 55150-385-01.
Reason for recall
Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.
Distribution pattern
Nationwide in the USA
Code information
Lot #: 3TC22010, Exp 11/30/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0041-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026